Pharma IQ Members

Informatics

Find out which informatics are right for your lab. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in pharmaceutical, biotech and life science laboratories to exchange ideas on best practice and share case studies on laboratory innovation and automation within the area.

Contributor: Social Monsters.org
Posted: 14/02/2017
default profile icon
After years of resistance, the health care and pharmaceutical industries are now accelerating full steam towards the cloud. In fact, the global health care cloud computing market, valued at $4.5 billion in 2016, will reach $9.5 billion by 2020. Here are the dominant benefits that are drawing these giants to the cloud. Full Article »
Contributor: Gerald Clarke
Posted: 24/03/2014
The informatics landscape is changing quickly and innovation could be the key to increasing efficiency. Jeff Hurst, Senior Scientist at the Hershey's Company talks us through these changes and how the industry is moving away from robots towards more innovative methods including mobile apps. He also talks about the dangers of becoming overly ' Full Podcast »
Contributor: Andrew Love
Posted: 10/09/2014
Andrew Love
In the final article in his serialisation series, Andrew Love looks at what needs to be done to commence the development of your strategy and implementation of your solutions. Andrew outlines the challenges you are likely to face such as identifying and interpreting the emerging and evolving legislation or Understanding the immature and evolving solution supply base and selecting appropriate implementation partners. He outlines solutions to these problems to clear your path to serialisation implementation Full Column »
Posted: 20/12/2016
Software design, medical devices, med devices, software for medical devices, medical software, apps
The Medical Device Technologies Market is forecasted to undergo exponential growth from 2015 up to 2021. Forecasted global market value for emerging medical device technologies by 2021: £90.8bn This is from 2016’s valuation of $55.9 billion Full Whitepaper »